CRG
Menu Internet
English SelectedChange language to SpanishChange language to Latin American Spanish
Buscador_Home Buscador_Home
Search
 Epigenetic Events in Cancer
Group Leader:



icrea

1996 PhD Dept. Cellular and Developmental Biology, University of Rome, Italy.
1996-2000 Postdoctoral work at the University of Marburg, Germany.
2000-2002 Senior Investigator at the European Institute of Oncology, Milan, Italy.
2003 Group Leader at the Centre de Regulació Genòmica(CRG), Barcelona, Spain. Research Professor, (ICREA) Institució Catalana de Recerca i Estudis Avançats

Summary
Understanding the genetic basis of cancers has been a topic of intense research, and hundreds of gene mutations have been identified that can cause carcinogenesis. However, in the past few years, increasing evidence has suggested that mutations are not the only genetic changes that lead to cancer. Indeed, perturbations of chromatin structure and of other epigenetic mechanisms can cause inappropriate gene expression and genomic instability, resulting in cellular transformation and malignant outgrowth.
Our research investigation is focused on understanding the role of several protein complexes that are involved in chromatin dynamics and metabolism, which when altered could participate in the establishment and maintenance of the aberrant silencing of tumor suppressor genes during transformation. Our results suggested that the Nucleosome Remodelling and Deacetylase complex (NuRD), Polycomb group of proteins (PcG) and the histone variant macroH2A are - with different timing and kinetics - involved in setting up an altered chromatin structure with aberrant gene silencing in acute promyelocytic leukemia (APL). We believe that the results of our research will lead to the identification of new biological tools with a potential impact on cancer therapeutic intervention.

Last modification: 29/02/2008


Research Lines
Other Activities
Selected Publications

Buschbeck M, Uribesalgo I, Wibowo I, Rué P, Martin D, Gutierrez A, Morey L, Guigó R, López-Schier H, Di Croce L.
"The histone variant macroH2A is an epigenetic regulator of key developmental genes".
Nat Struct Mol Biol. 16(10):1074-9. Epub 2009 Sep 6. (2009). PubMed ID: 19734898.abstract
Cardamone MD, Bardella C, Gutierrez A, Di Croce L, Rosenfeld MG, Di Renzo MF, De Bortoli M..
ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells.
Proc Natl Acad Sci U S A. 106(18): 7420–7425 (2009). PubMed ID: 19383788.abstract
Morey L, Brenner C, Fazi F, Villa R, Gutierrez A, Buschbeck M, Nervi C, Minucci S, Fuks F, Di Croce L..
MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.
Mol Cell Biol. 28(19):5912-23. (2008). abstract
Di Croce L, Shiekhattar R..
Thrilling transcription through threonine phosphorylation
Nat Cell Biol. 10(1):5-6. (2008). abstract
Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D, Di Croce L, Shiekhattar R.
"Demethylation of H3K27 Regulates Polycomb Recruitment and H2A Ubiquitination".
Science. 318(5849):447-50 (2007). abstract

Other information about the group


Group Members


Epigenetic Events in Cancer